Filing Details
- Accession Number:
- 0001127602-15-007937
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-24 16:23:10
- Reporting Period:
- 2015-02-20
- Filing Date:
- 2015-02-24
- Accepted Time:
- 2015-02-24 16:23:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242992 | P Timothy Clackson | C/O Ariad Pharmaceuticals Inc 26 Landsdowne Street Cambridge MA 02139 | President, R&D, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-20 | 24,999 | $2.62 | 453,231 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-20 | 24,999 | $8.00 | 428,232 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-02-20 | 24,036 | $4.49 | 452,268 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-20 | 24,036 | $8.00 | 428,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-02-20 | 24,999 | $0.00 | 24,999 | $2.62 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-02-20 | 24,036 | $0.00 | 24,036 | $4.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-12-08 | 2019-12-08 | No | 4 | M | Direct |
| 31,422 | 2008-04-16 | 2017-04-16 | No | 4 | M | Direct |
Footnotes
- Shares were acquired upon the exercise of outstanding stock options at $2.62 per share.
- This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in June 2014.
- Shares were acquired upon the exercise of outstanding stock options at $4.49 per share.
Billionaire Hedge Funds
